Skip to Main Content

Author Details

Michael Sch??ll
University of Gothenburg
2011
116
47
PMIDPaper TitleJournal TitlePublished Year
37767905CT-based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration.Alzheimers Dement2024
35971593Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.Alzheimers Dement2023
37659430Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.Lancet Healthy Longev2023
37578787Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.JAMA Neurol2023
37016464APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.Alzheimers Res Ther2023
37284793Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.Brain2023
37231491Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir study.Alzheimers Res Ther2023
37267297Advances in Alzheimer's Disease.Brain Connect2023
37201176Operationalizing the centiloid scale for [<sup>18</sup>F]florbetapir PET studies on PET/MRI.Alzheimers Dement (Amst)2023
36994314Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.Alzheimers Dement (Amst)2023
36881266Image-derived input functions from dynamic <sup>15</sup>O-water PET scans using penalised reconstruction.EJNMMI Phys2023
36761917The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.Front Neurol2023
34924376Association of APOE ɿ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.J Alzheimers Dis2022
35604688Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.JAMA Netw Open2022
35659709Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies.Mol Neurodegener2022
35654597Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.Neurology2022
36426215Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944.Front Digit Health2022
36044030Good manufacturing procedure production of [<sup>18</sup> F]SynVesT-1, a radioligand for in vivo positron emission tomography imaging of synaptic vesicle glycoprotein 2A.J Labelled Comp Radiopharm2022
36345046Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease.Alzheimers Res Ther2022
35226405CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.Alzheimers Dement2022
35280965Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds.Alzheimers Dement (Amst)2022
35084051Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.Ann Neurol2022
35082608Comparison of Two-Dimensional- and Three-Dimensional-Based U-Net Architectures for Brain Tissue Classification in One-Dimensional Brain CT.Front Comput Neurosci2022
33475761Reduced [<sup>18</sup>F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.Eur J Nucl Med Mol Imaging2021
33521872Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.Eur J Nucl Med Mol Imaging2021
33742656Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.Brain2021
33491853The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.Alzheimers Dement2021
33484167Pre- and postoperative <sup>68</sup> Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours.Clin Endocrinol (Oxf)2021
33585983Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.Acta Neuropathol2021
33579845Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.J Alzheimers Dis2021
34571160Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT.Neuroimage2021
34510001Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.J Neurol Neurosurg Psychiatry2021
34654920Publisher Correction: Microglial activation and tau propagate jointly across Braak stages.Nat Med2021
34446931Microglial activation and tau propagate jointly across Braak stages.Nat Med2021
34099648A multicentre validation study of the diagnostic value of plasma neurofilament light.Nat Commun2021
34295959Current advances in digital cognitive assessment for preclinical Alzheimer's disease.Alzheimers Dement (Amst)2021
34266917Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.Neurology2021
34200180Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.Int J Mol Sci2021
33257949Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.Brain2021
33370497Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.Eur J Neurol2021
33427873Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.JAMA Neurol2021
33106600Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.Mol Psychiatry2021
31612245Head-to-head comparison of tau positron emission tomography tracers [<sup>18</sup>F]flortaucipir and [<sup>18</sup>F]RO948.Eur J Nucl Med Mol Imaging2020
31868239Lower <sup>68</sup> Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland-A proof-of-concept study.Clin Endocrinol (Oxf)2020
32019594University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019-course organisation.Alzheimers Res Ther2020
31886490Does early cognitive decline require the presence of both tau and amyloid-β?Brain2020
31735253Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.Biol Psychiatry2020
33210117Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.Brain2020
32340618Imaging biomarkers in neurodegeneration: current and future practices.Alzheimers Res Ther2020
32333900Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.Lancet Neurol2020
  • 1 - 50 of 116

Recommended Authors

Massachusetts General Hospital, Harvard Medical School
Career Start Year 2012
Number of shared co-authors 14
Maastricht University
Career Start Year 2011
Number of shared co-authors 4
Indiana University School of Medicine
Career Start Year 2009
Number of shared co-authors 11
Mayo Clinic Rochester
Career Start Year 2006
Number of shared co-authors 7
University of California davis
Career Start Year 2005
Number of shared co-authors 1
Indiana University Network Sciences Institute
Career Start Year 2005
Number of shared co-authors 17
Banner Alzheimer's Institute, University of California
Career Start Year 2001
Number of shared co-authors 12
University of California san francisco
Career Start Year 2000
Number of shared co-authors 7
Brain Health Imaging Institute
Career Start Year 1999
Number of shared co-authors 12
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 7
University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 14
University of Montreal
Career Start Year 1998
Number of shared co-authors 1
Beijing Normal University
Career Start Year 1993
Number of shared co-authors 14
Brigham and Women's Hospital, Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 21
University of Kentucky
Career Start Year 1991
Number of shared co-authors 17
Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine
Career Start Year 1990
Number of shared co-authors 17
University of British Columbia
Career Start Year 1990
Number of shared co-authors 18
Yale University School of Medicine
Career Start Year 1990
Number of shared co-authors 12
Eisai Inc.
Career Start Year 1989
Number of shared co-authors 11
Butler Hospital, and Warren Alpert Medical School of Brown University
Career Start Year 1988
Number of shared co-authors 18
Barrow Neurological Institute
Career Start Year 1988
Number of shared co-authors 13
Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Career Start Year 1987
Number of shared co-authors 18
Mayo Clinic Rochester
Career Start Year 1984
Number of shared co-authors 19
Washington University School of Medicine
Career Start Year 1984
Number of shared co-authors 19
Banner Alzheimer's Institute
Career Start Year 1984
Number of shared co-authors 17
Massachusetts General Hospital
Career Start Year 1981
Number of shared co-authors 16
University of Utah
Career Start Year 1980
Number of shared co-authors 13
Lou Ruvo Center for Brain Health, Cleveland Clinic
Career Start Year 1980
Number of shared co-authors 12
Mayo Clinic Rochester
Career Start Year 1975
Number of shared co-authors 14
Mayo Clinic Rochester
Career Start Year 1968
Number of shared co-authors 17

Collaborators

Instituto de Salud Carlos III
Co-authored papers 11
Heidelberg University Hospital, Ruprecht Karls University of Heidelberg
Co-authored papers 10
Heidelberg University Hospital, Ruprecht Karls University of Heidelberg
Co-authored papers 10
Helen Wills Neuroscience Institute, University of California Berkeley
Co-authored papers 9
Heidelberg University Hospital, Ruprecht Karls University of Heidelberg
Co-authored papers 8
Co-authored papers 8
Max-Planck-Institute for Neurological Research
Co-authored papers 4
UK Dementia Research Institute, University College London
Co-authored papers 4
Janssen Medical Ltd
Co-authored papers 4
Department of Basic and Clinical Neuroscience, King's College London
Co-authored papers 3
Institut fur Physik, Humboldt-Universitat zu Berlin
Co-authored papers 3
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 3
University Hospital Cologne
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Rigshospitalet, University of Copenhagen
Co-authored papers 2
Neurovascular Research Unit, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 2
Medical University of Innsbruck
Co-authored papers 2
Robert Koch Institute
Co-authored papers 2
University of Cologne
Co-authored papers 2
Brain Health Imaging Institute
Co-authored papers 2
Interuniversity Microelectronics Centre
Co-authored papers 2
University of Cincinnati
Co-authored papers 2
1 Center for Stroke Research Berlin, Charite University Medicine Berlin
Co-authored papers 2
Jena University Hospital - Friedrich Schiller University of Jena
Co-authored papers 2
University of New Mexico
Co-authored papers 2
Queen's University
Co-authored papers 2
Alzheimer's Therapeutic Research Institute, University of Southern California
Co-authored papers 2
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 2
University of Utah School of Medicine
Co-authored papers 2
Center for Stroke Research Berlin, Charite University
Co-authored papers 2